Although GLP-1RAs have shown remarkable efficacy in weight management, several barriers limit their full integration into mainstream obesity care
Very low intake may worsen fatigue, reduce activity, increase constipation, and contribute to muscle loss
GLP-1 medications are complex peptide-based drugs that are expensive to manufacture, relatively new, and still under patent protection for brand-name versions
These approaches remain largely experimental and should be discussed with a qualified healthcare provider
Obesity Research: Pre-clinical obesity studies have reported substantial effects on body weight, food intake, and fat mass in animal models, with research attributing the breadth and magnitude of these effects to the combined tri-receptor mechanism particularly the additive contribution of glucagon receptor-driven energy expenditure alongside dual incretin activity
Many Scottsdale patients choose us for FDA-approved GLP-1 weight loss treatments like Semaglutide, Tirzepatide, and Phentermine under expert medical supervision
.png?width=1280&auto=webp&quality=80&format=jpg&disable=upscale)
